Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307, United States
NCT Number: NCT00413751
The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Observational
Washington D.C., District of Columbia, 20307, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Walter Reed Army Medical Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01866852
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT05531396
Elderly, Healthy
Taipei, Taiwan
View Trial DetailsNCT07629414
Healthy, Heat Stress Disorders
Shreveport, Louisiana, United States
View Trial DetailsNCT07531628
Healthy
Hangzhou, China
View Trial Details